Is this you? Create Your Porfile
Avatar

Dirk Finsinger

Merck & Co.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Dirk Finsinger is active.

Explore More

Publication

Featured researches published by Dirk Finsinger.

Archive | 1998

Peptide-coated implants and methods for producing same

Jörg Meyer; Alfred Jonczyk; Berthold Nies; Horst Kessler; Dirk Finsinger; Martin Kantlehner

Archive | 2004

2-(hetero)aryl-substituted tetrahydroquinoline derivatives

Kai Schiemann; Ulrich Emde; Dirk Finsinger; Johannes Gleitz; Helmut Reubold; Frank Zenke

Archive | 2003

Methylene urea derivatives as raf-kinase inhibitors

Hans Peter Buchstaller; Matthias Wiesner; Oliver Schadt; Christiane Amendt; Frank Zenke; Christian Sirrenberg; Matthias Grell; Dirk Finsinger

Archive | 2004

Benzimidazole derivatives as raf kinase inhibitors

Hans-Peter Buchstaller; Dirk Finsinger; Matthias Wiesner; Lars Thore Burgdorf; Christiane Amendt; Matthias Grell; Christian Sirrenberg; Frank Zenke

Archive | 2007

TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN

Kai Schiemann; Dirk Finsinger; Frank Zenke

Archive | 1998

Cyclopeptide derivatives with integrin inhibitor properties

Jörg Meyer; Alfred Jonczyk; Berthold Nies; Horst Kessler; Dirk Finsinger; Martin Kantlehner

Archive | 2004

Substituted pyrazole compounds

Oliver Schadt; Michael Arlt; Dirk Finsinger; Kai Schiemann; Christoph Van Amsterdam; Gerd Bartoszyk; Christoph Seyfried

Archive | 2003

Methylene urea derivatives

Hans-Peter Buchstaller; Matthias Wiesner; Oliver Schadt; Christiane Amendt; Frank Zenke; Christian Sirrenberg; Matthias Grell; Dirk Finsinger

Archive | 2008

Tetrahydroquinoline derivatives and use of same for treating cancer

Kai Schiemann; Dirk Finsinger; Christiane Amendt; Frank Zenke

Archive | 2007

New fused-ring diazepinone compounds, useful for treatment and prevention of e.g. cancers and arteriosclerosis, are inhibitors of serine-threonine kinase

Melanie Schulz; Lars Thore Burgdorf; Dirk Finsinger; Andree Blaukat; Hartmut Greiner; Christina Esdar; Hans-Georg Kreysch; Tanja Henzler

Explore More

Collaboration

Dive into the Dirk Finsinger's collaboration.

Top Co-Authors
Avatar

Frank Zenke

Merck

View shared research outputs
Top Co-Authors
Avatar

Christiane Amendt

Merck

View shared research outputs
Top Co-Authors
Avatar

Kai Schiemann

Merck

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Buchstaller

Merck

View shared research outputs
Top Co-Authors
Avatar

Christian Sirrenberg

Merck

View shared research outputs
Top Co-Authors
Avatar

Matthias Grell

Merck

View shared research outputs
Top Co-Authors
Avatar

Matthias Wiesner

Merck

View shared research outputs
Top Co-Authors
Avatar

Oliver Schadt

Merck

View shared research outputs
Top Co-Authors
Avatar

Lars Thore Burgdorf

Merck

View shared research outputs
Top Co-Authors
Avatar

Ulrich Emde

Merck

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge